BIO SPARK SHOWCASE : Session Three

okt 18, 2018: 7 p.m. - 7:30 p.m.
California West

The BIO SPARK Showcase aims to provide an excellent opportunity for academic researchers in the SPARK network to showcase drug development programs that are ready for partnering or venture funding.

The BIO Investor Forum is historically well attended by the venture arms and business development units of major pharmaceutical companies, smaller specialty pharma/biotech companies looking to add to their pipelines, start-ups, and many early stage venture capital firms, making it the ideal setting for early stage assets from the university setting. Academics interested in partnering will present their programs and also have one-on-one discussions with interested parties.

Stanford University
Platform technology for gene delivery
Ole Audun Werner Haabeth
SPARK Taiwan
Development of the drug to treat opioid addiction
Amy Lai
SPARK Australia- Monash University
Curative approach to inflammatory and autoimmune diseases
Professor Charles Mackay
Stanford University- Facile Therapeutics
Development of a de-risked, phase 2-ready treatment for C. difficile infections
Marc Navre